How Is MHC Class I Involved in Personalized Cancer Vaccines?
Personalized cancer vaccines are designed to elicit a strong immune response specifically against TAAs presented by MHC Class I molecules. By identifying and targeting unique antigens present on an individual’s tumor, personalized vaccines can potentially enhance the immune system's ability to recognize and kill cancer cells, leading to more effective treatments.
